Product Images Ticagrelor

This text outlines recommendations for adjusting Ticagrelor doses when interacting with different drugs. It includes information on drugs such as Simvastatin, Atorvastatin, Levonorgestrel, Ethinyl Estradiol, Tolbutamide, Digoxin, and Cyclosporine. Specific dose adjustments and monitoring suggestions are provided based on the interacting drug to ensure safe and effective use of Ticagrelor.*

This text seems to be data related to a comparison between Ticagrelor and Clopidogrel dosages, categorizing regions and outcomes in terms of efficacy. It includes information on the number of participants, hazard ratios, and confidence intervals for different dosage ranges in US and non-US regions. The last line seems to suggest a comparison verdict stating "Ticagrelor Better" over "Clopidogrel Better."*

Each tablet contains 60 mg ticagrelor. This medication is intended for adults - dosage requirements can be found in the package insert. Safety precautions should be observed, including keeping the medication out of children's reach. Storage temperature should not exceed 86°F. The Medication Guide can be accessed at the provided website. Dispense the Medication Guide alongside the medication to each patient. The medication is manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Radha Pharmaceuticals, Inc.*

This text provides information about IPA (%) induced by 20uM ADP over time with Ticagrelor, Clopidogrel, and Placebo. It seems to be related to a study or experiment tracking the effects of these substances on platelet aggregation.*

This text outlines the mean effect and 90% confidence intervals for the drug Ticagrelor ARI24910 along with recommendations for its use based on intrinsic factors like age, gender, ethnicity, renal function, and hepatic impairment. It specifies that no dose adjustments are needed for individuals falling into particular categories within these factors. Additionally, it notes that Ticagrelor can be administered in patients with moderate to severe hepatic impairment.*

This is a list of interacting drugs and their effects on Ticagrelor AR-C124910XX with recommendations based on the strength of interactions, such as strong, moderate, or potent inhibitors and inducers of CYP3A4. The text provides specific examples of medications like Ketoconazole, Diltiazem, Rifampin, Aspirin, Desmopressin, Heparin, and Enoxaparin, along with their recommended dosages and administration frequency. Additionally, it mentions P-glycoprotein inhibitors like Cyclosporine and Fentanyl with their respective doses. The document also includes changes relative to a reference point, potentially regarding pharmacokinetics.*

This text provides information about Ticagrelor tablets, with each tablet containing 90 mg of Ticagrelor. The usual adult dosage should be confirmed by referring to the package insert. It includes a warning to keep the medication out of the reach of children and to store it at 25°C (77°F). The text also mentions a link to print the Medication Guide and provides details about the manufacturer and distributor.*